Product Information
HALOPERIDOL DEC 50 MG/ML VIAL is a generic product labeled by Somerset Therapeutics, LLC, priced at $12.6780 per ML under NDC 70069038101. Its NADAC has been published 203 times since Sep 23, 2020.
FDA first approved this application on Jul 3, 2018. Its Orange Book therapeutic-equivalence code is AO.
Strength
50 mg/mL
Manufacturer
Somerset Therapeutics, LLCNDC
70069038101
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
HALOPERIDOL DECANOATEApproval Type
Generic (ANDA)
FDA Application
ANDA209101FDA Approved
7/3/2018
TE Code
AO
On Market Since
4/4/2019
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL DEC 50 MG/ML VIAL has been published 203 times since Sep 23, 2020, and over the history we have for it it has declined 38.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.6780 per ML |
|---|---|
| All-time high | $20.7200 (Feb 10, 2021) |
| All-time low | $11.6628 (Mar 18, 2026) |
| 52-week high | $12.8162 |
| 52-week low | $11.6628 |
| Median price | $15.4150 |
| Average price | $16.1339 |
| Largest weekly change | -11.3% (Sep 18, 2024) |
| Weeks tracked | 203 |
| Tracking since | Sep 23, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 48% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Somerset Therapeutics, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
HALOPERIDOL DECANOATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL DEC 50 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL DEC 50 MG/ML VIAL, manufactured by Somerset Therapeutics, LLC, is $12.6780 per ML (NDC 70069038101), effective Sep 30, 2026.
How has the price of HALOPERIDOL DEC 50 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL DEC 50 MG/ML VIAL has declined 38.8%. It has been tracked across 203 weekly CMS publications since Sep 23, 2020.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL DEC 50 MG/ML VIAL?
Since Sep 23, 2020, the NADAC for HALOPERIDOL DEC 50 MG/ML VIAL has ranged from a low of $11.6628 (Mar 18, 2026) to a high of $20.7200 (Feb 10, 2021), with a median of $15.4150 per ML.
Are there cheaper alternatives to HALOPERIDOL DEC 50 MG/ML VIAL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HALOPERIDOL DEC 50 MG/ML VIAL, is $6.5723 per ML — about 48% below HALOPERIDOL DEC 50 MG/ML VIAL.
Who manufactures HALOPERIDOL DEC 50 MG/ML VIAL?
HALOPERIDOL DEC 50 MG/ML VIAL (NDC 70069038101) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.